By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

uniQure 

Meibergdreef 61

  Amsterdam  1105 BA  Netherlands
Phone: 31-20-566-7394 Fax: 31-20-566-9272


SEARCH JOBS


Industry
Pharmaceutical






Company News
uniQure (QURE) Presents New Preclinical Data On AMT-130 In Huntington’s Disease At CHDI’s 12th Annual Huntington’s Disease Therapeutics Conference 4/26/2017 10:45:21 AM
uniQure (QURE) Receives EMA Priority Medicines (PRIME) Designation For AMT-060 In Hemophilia B 4/25/2017 9:01:25 AM
uniQure (QURE) Announces It Will Not Seek Marketing Authorization Renewal For Glybera In Europe 4/20/2017 8:57:58 AM
uniQure (QURE) Publishes Data Demonstrating Wide Distribution Of AAV5 In The Central Nervous System 4/4/2017 3:01:23 PM
uniQure (QURE) Announces Presentations At Upcoming April Conferences 4/3/2017 1:00:06 PM
uniQure (QURE) Announces 2016 Financial Results And Provides Update On Company Progress 3/15/2017 9:26:25 AM
uniQure (QURE) Receives 2017 Frost & Sullivan Manufacturing Leadership Award 3/3/2017 7:32:12 AM
uniQure (QURE) Announces Presentations At Upcoming March Conferences 3/1/2017 7:48:30 AM
uniQure (QURE) Announces Presentations At Upcoming February Conferences 2/6/2017 8:00:11 AM
uniQure (QURE) Announces FDA Breakthrough Therapy Designation For AMT-060 In Hemophilia B 1/30/2017 9:17:21 AM
12345678910...
//-->